Haermonics
Eindhoven, NL · 2 known investors
Haermonics is a clinical-stage medtech company that developed the Haermonics Pure System, a continuous postoperative pericardial flush therapy designed to keep chest tubes clear and prevent bleeding-related complications after open-heart cardiac surgery. The device targets retained blood syndrome and the need for surgical re-exploration in cardiac surgery patients.
HardwareHealthtechMedical Devices
Founders & leadership
DR
David R. KoolbergenInventor of the therapy; Congenital Cardiothoracic Surgeon